GALDERMA LABS LP FDA Approval NDA 020748

NDA 020748

GALDERMA LABS LP

FDA Drug Application

Application #020748

Documents

Review2003-05-08
Letter2000-05-26
Label2000-05-26

Application Sponsors

NDA 020748GALDERMA LABS LP

Marketing Status

Prescription001

Application Products

001CREAM;TOPICAL0.1%1DIFFERINADAPALENE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2000-05-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2013-02-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2014-08-01STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL8Null0
SUPPL9Null0

TE Codes

001PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20748
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.